HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrick Round Selected Research

S66913

4/2018A double-blind, randomised, placebo-controlled, cross-over study assessing the use of XEN-D0103 in patients with paroxysmal atrial fibrillation and implanted pacemakers allowing continuous beat-to-beat monitoring of drug efficacy.
2/2016The positive frequency-dependent electrophysiological effects of the IKur inhibitor XEN-D0103 are desirable for the treatment of atrial fibrillation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrick Round Research Topics

Disease

2Atrial Fibrillation
04/2018 - 02/2016
1Cough
11/2017
1Chronic Cough
11/2017
1Cardiovascular Diseases (Cardiovascular Disease)
08/2015
1Congenital Heart Defects (Congenital Heart Defect)
01/2014

Drug/Important Bio-Agent (IBA)

2S66913IBA
04/2018 - 02/2016
2Pharmaceutical PreparationsIBA
04/2018 - 01/2014
1Capsaicin (Zostrix)FDA Link
11/2017
1SB 705498IBA
11/2017
1LipidsIBA
08/2015